1. Home
  2. SION vs ARKO Comparison

SION vs ARKO Comparison

Compare SION & ARKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • ARKO
  • Stock Information
  • Founded
  • SION 2019
  • ARKO 1970
  • Country
  • SION United States
  • ARKO United States
  • Employees
  • SION N/A
  • ARKO N/A
  • Industry
  • SION
  • ARKO Oil Refining/Marketing
  • Sector
  • SION
  • ARKO Energy
  • Exchange
  • SION NYSE
  • ARKO Nasdaq
  • Market Cap
  • SION 583.9M
  • ARKO 522.1M
  • IPO Year
  • SION 2025
  • ARKO N/A
  • Fundamental
  • Price
  • SION $17.10
  • ARKO $3.83
  • Analyst Decision
  • SION Strong Buy
  • ARKO Hold
  • Analyst Count
  • SION 1
  • ARKO 3
  • Target Price
  • SION $32.00
  • ARKO $6.58
  • AVG Volume (30 Days)
  • SION 202.1K
  • ARKO 1.2M
  • Earning Date
  • SION 01-01-0001
  • ARKO 05-06-2025
  • Dividend Yield
  • SION N/A
  • ARKO 3.13%
  • EPS Growth
  • SION N/A
  • ARKO N/A
  • EPS
  • SION N/A
  • ARKO 0.13
  • Revenue
  • SION N/A
  • ARKO $8,731,962,000.00
  • Revenue This Year
  • SION N/A
  • ARKO N/A
  • Revenue Next Year
  • SION N/A
  • ARKO N/A
  • P/E Ratio
  • SION N/A
  • ARKO $29.97
  • Revenue Growth
  • SION N/A
  • ARKO N/A
  • 52 Week Low
  • SION $13.21
  • ARKO $3.76
  • 52 Week High
  • SION $25.19
  • ARKO $7.84
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • ARKO 21.96
  • Support Level
  • SION N/A
  • ARKO $3.76
  • Resistance Level
  • SION N/A
  • ARKO $4.29
  • Average True Range (ATR)
  • SION 0.00
  • ARKO 0.39
  • MACD
  • SION 0.00
  • ARKO -0.18
  • Stochastic Oscillator
  • SION 0.00
  • ARKO 1.93

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which Heads to insufficient CFTR function.

About ARKO ARKO Corp.

ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.

Share on Social Networks: